Present and Emerging Strategies for Disease Assessment in Hodgkin Lymphoma
{{output}}
Emerging treatment paradigms in classic Hodgkin lymphoma (cHL), which increasingly incorporate immunotherapy and response-adapted strategies, have increased the need for more accurate disease assessment tools. PET/CT remains the cornerstone for staging and res... ...